Diagnostics boosts Roche's performance
This article was originally published in Clinica
Sales in Roche's diagnostic division increased 28% to SwFr966 million ($654 million) in the year ended December 31. Expressed in local currency terms, this represents 17% growth. Total sales were SwFr18,765 million, up 6% in local currencies.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.